These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17725633)

  • 1. Islet cell autoantibody levels after the diagnosis of young adult diabetic patients.
    Jensen R; Gilliam L; Torn C; Landin-Olsson M; Palmer J; Akesson K; Kockum I; Lernmark B; Karlsson AF; Lynch KF; Breslow N; Lernmark A; Sundkvist G;
    Diabet Med; 2007 Nov; 24(11):1221-8. PubMed ID: 17725633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H; Gottsäter A; Fernlund P; Sundkvist G
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity among patients with latent autoimmune diabetes in adults.
    Maruyama T; Nakagawa T; Kasuga A; Murata M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.
    Siraj ES; Rogers DG; Gupta MK; Reddy SS
    Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for the course of beta cell function in autoimmune diabetes.
    Törn C; Landin-Olsson M; Lernmark A; Palmer JP; Arnqvist HJ; Blohmé G; Lithner F; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L; Ostman J
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4619-23. PubMed ID: 11134117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
    Velluzzi F; Secci G; Sepe V; Klersy C; Shattock M; Foxon R; Songini M; Mariotti S; Locatelli M; Bottazzo GF; Loviselli A;
    Acta Diabetol; 2016 Feb; 53(1):73-9. PubMed ID: 25896008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.
    Törn C; Landin-Olsson M; Lernmark A; Scherstén B; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G
    Autoimmunity; 2001; 33(2):115-20. PubMed ID: 11264790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.